← SynDRA
ITX-5061 FREE BASE
SynDRA canonical compound SYN0023690 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | MAPK14 |
|---|
| Mechanism of action | SR-BI inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- MAPK14 INHIBITOR
- MAP kinase p38 alpha inhibitor
- SR-BI inhibitor
Cross-references
Synonyms
- UNII-RDD1D7O9YX
- RDD1D7O9YX
- KC-706 FREE BASE
- RefChem:150236
- DTXCID30156367
- SCHEMBL1598868
- SCHEMBL29437772
- UUROSJLZNDSXRF-UHFFFAOYSA-N
- BDBM50323654
- AKOS025158440
- SB17514
- DB-214152
- BRD-K76911699-001-01-6
- BRD-K76911699-001-02-4
- Itx-5061
- MFCD30532738
- T15603
- KC706
- CS-0016951
- HY-19900
- itx-5061
- UNII-J4RA8K2Q2A
- CHEMBL3402567
- ITX5061
- J4RA8K2Q2A
- CAC67952
- 1-Naphthaleneacetamide, N-(5-(1,1-dimethylethyl)-2-methoxy-3- ((methylsulfonyl)amino)phenyl)-4-(2-(4-morpholinyl)ethoxy)-alpha-oxo-, hydrochloride (1:1)
- SCHEMBL29437767
- C30H38ClN3O7S
- GLXC-15672
- ITX 5061
- AKOS040741891
- G15934
- DA-74610
- KC-706
- orb1707167
- EX-A4531
Look up ITX-5061 FREE BASE in the interactive SynDRA portal →